Avenue Pierre Brossolette, 1
91385, Chilly-Mazarin
FRANCE
sanofi.com
Project leader
 |
|
| Dr. Cecile Orsini |
| |
| Phone |
+33 1 58 93 31 30 |
| E-Mail |
|
|
|
Project staff
 |
|
| Dr. Jean-Michel Guillon |
| |
| Phone |
+33 1 58 93 85 59 |
| E-Mail |
|
|
|
|
|
| Dr. Gilles Labbe |
| |
| Phone |
+33 1 58 93 35 27 |
| E-Mail |
|
|
|
|
|
| Dr. Jean-Pierre Martinolle |
| |
| Phone |
+33 4 99 77 60 49 |
| E-Mail |
|
|
|
|
|
| Dr. Marie-Christine Multon |
| |
| Phone |
+33 1 58 93 34 770 |
| E-Mail |
|
|
|
|
|
| Dr. Michel Partiseti |
| |
| Phone |
+33 1 58 93 29 96 |
| E-Mail |
|
|
|
|
|
| Dr. Emmanuel Spanakis |
| |
| Phone |
+33 1 58 93 34 35 |
| E-Mail |
|
|
|
Institute presentation
Within the SANOFI pharmaceutical group, Sanofi-Aventis Recherche & Developpement (SARD) focuses on finding innovative solutions to major public health challenges and to patients’ needs.
The group concentrates its efforts on several major priorities including diabetes, oncology, ophthalmology, infectious diseases, aging, neurodegenerative diseases, immuno-inflammation, fibrosis and tissue repair. Sanofi-Aventis Recherche & Developpement (SARD) through three departments (Global Biotherapeutics, DSAR: Disposition, Safety & Animal Research and LGCR: Lead Generation to Candidate Realization) is involved in StemBANCC in 7 work-packages out of 12.
